Biocryst Pharmaceuticals BCRX
NASDAQ BCRX
$8.23 -0.04 (-0.47%)
As of: Sep 30, 2026 · 10:25 AM EDT

Biocryst Pharmaceuticals (BCRX) EV to EBITDA (2025)

Updated

Biocryst Pharmaceuticals' EV to EBITDA came in at 4.05 for Q4 2025, down 77.4% from the prior quarter.

Analysis

Biocryst Pharmaceuticals (BCRX) EV to EBITDA (2025) Analysis & Trends

Going back to Q1 2025, Biocryst Pharmaceuticals' EV to EBITDA data covers 4 quarters.

  • Business Quant data shows BCRX's EV to EBITDA at 17.89 (Q3 2025), 29.21 (Q2 2025) and 36.99 (Q1 2025) in the three quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Biocryst Pharmaceuticals 2.16 Bn 1.08 Bn 214.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.05
Sep 30, 2025 17.89
Jun 30, 2025 29.21
Mar 31, 2025 36.99
API Access

Biocryst Pharmaceuticals EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=BCRX&period=max&api_key=YOUR_API_KEY